Onconova Therapeutics Inc. (ONTX): Share price closed at $1.10 on Tuesday, August 04

0
29

Onconova Therapeutics Inc. (NASDAQ:ONTX) changes shares on Tuesday trading session, with a change of -3.51% or -$0.04 shares. The trading starts at $1.11 and closed at $1.14 throughout the day. The trading session low price was $1.08 and day high was $1.14 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 6.59 million while its average volume is 16.19M. In other hand, the ONTX market cap reached to $190.34M.

On July 10, 2020, BRIEF-Onconova Therapeutics Says Compensation Committee Approved A Cash Bonus Program Of Cash-Settled SAR And Cash-Settled PSU To Employees. According to the news reported on Reuters, * ONCONOVA THERAPEUTICS INC – COMPENSATION COMMITTEE APPROVED A CASH BONUS PROGRAM OF CASH-SETTLED SAR AND CASH-SETTLED PSU TO EMPLOYEES Source text: [https://bit.ly/2CokShr] Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -2.65% and up 90.15% for month. Its quarterly performance was 257.96% above, while its half year performance is up 193.41%. ONTX yearly performance stood at negative -54.36% and rise 187.21% for year-to-date. Current recommendation for Onconova Therapeutics Inc. is 2.00.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. ONTX EPS (TTM) for 12-month is -1.52. EPS for this year is 70.00%, while for the next year its value is -0.14. Its EPS Q/Q reached 97.50%. It has an EPS of 67.90% up for past five years.

Let’s take a look on the analyst recommendations on ONTX for the current month and previous month. For the current month, 4 of 4 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $1.30 – $3.00. Average target price for ONTX was reached at $2.08.

The insider ownership moved to 0.20% and institutional holding shifted to 7.80%.

The company posted an EPS (TTM) of -1.52. According to the most recent quarter report on (Jun 2020), 3 analysts estimated an average EPS of -0.03, while -0.6 EPS posted a year ago period. Analyst Estimated EPS for ONTX published in the report was -$0.03 – -$0.03 during the same period. Comparing with last year, the average estimated EPS was -0.6 which is lower than -0.03 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for ONTX rise 134.10% for period of 200 days. SMA for 50 days was 60.73% which is showing green signal, while SMA-20 was 18.69%. The moving average value for Onconova Therapeutics Inc. (ONTX) is 6.37M and 4.50% for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in ONTX stock. On May 19, GROOPMAN JEROME, Director, bought 10,000 trading shares at the cost of $0.36, which valued at 3626.0. On May 19, OLER ABRAHAM N., SVP Corp Dev & Gen Counsel, bought 15,000 shares at the cost of $0.37, with total shares of 90,000. On May 19, Guerin Mark Patrick, Chief Financial Officer, bought 21,000 shares at the cost of 0.36. After this transaction, Guerin Mark Patrick total shares reached to 108,844 which valued at 7560.0.